September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Mark Roschewski: Precise Remission Assessment in LBCL Using PhasED-Seq ctDNA
Aug 15, 2025, 14:48

Mark Roschewski: Precise Remission Assessment in LBCL Using PhasED-Seq ctDNA

Mark Roschewski, Senior Clinician at National Cancer Institute (NCI), shared on X:

“Remission Assessment by Circulating Tumor DNA in Large B-cell Lymphoma | Journal of Clinical Oncology

Read this paper which shows that ctDNA MRD by PhasED-Seq is the most precise way to define a remission after therapy for LBCL.”

Title: Remission Assessment by Circulating Tumor DNA in Large B-cell Lymphoma

Authors: Mark Roschewski, David M. Kurtz, Jason R. Westin, Ryan C. Lynch, Ajay K. Gopal, Stefan K. Alig, Brian J. Sworder, Hua-Jay J. Cherng, Christian Kuffer, Derek Blair, Krystal Brown, Jordan S. Goldstein, Andre Schultz, Sandra Close, Jacob J. Chabon, Maximilian Diehn, Wyndham H. Wilson, Ash A. Alizadeh

Read the full article.

Mark Roschewski

More posts featuring Large B-cell Lymphoma.